目的 探讨神经内镜联合显微镜行微血管减压术治疗原发性三叉神经痛的临床疗效。方法 回顾分析78例行微血管减压术治疗的原发性三叉神经痛患者资料，其中常规显微镜组( A 组) 36 例，神经内镜联合显微镜微血管减压术( B 组)42例，分析比较两组术中责任血管发现率、手术并发症及术后疗效。 结果 B 组责任血管发现率( 95.2% ) 明显高于 A 组责任血管发现率 ( 80.6% ) 、治愈率（97.6%）高于A组（83.3%），两者差异均有统计学意义( P<0.05) ；术后并发症 B 组( 14.3% ) 比 A 组( 30.6% ) 无明显差异（P>0.05）。 结论 神经内镜联合显微镜微血管减压术治疗三叉神经痛有助于避免责任血管遗漏，提高责任血管发现率和手术治愈率。
关键词：
原发性三叉神经痛; ; ; 微血管减压术; ; ; 神经内镜; ; ; 显微镜
Objective To evaluate the clinical effect of primary trigeminal neuralgia treatment by neuroendoscopy combined with microvascular decompression under microscope. Methods A retrospective analysis was made on 78 patients with primary trigeminal neuralgia treated by microvascular decompression, with 36 cases were treated by microvascular decompression under microscope (group A), and the other 42 cases were treated under neuroendoscopy combined with microscope (group B).The discovery rate of offending vessels, complications rate, and therapeutic efficacy were compared in the two groups after treatment. Results The discovery rate of offending vessels in the group B (95.2%) was significantly higher than that of the group A (80.6%); The total effective rate of the group B (97.6%) was higher than that of the group A (83.3%). There were statistical differences in the discovery rate of offending vessels and total effective rate in the two groups (P<0.05). There was no statistical difference in the postoperative complications between group A (30.6%) and group B (14.3%) (P>0.05). Conclusions The treatment of primary trigeminal neuralgia with neuroendoscopy combined with microvascular decompression microscope is of high clinical application value to improve the discovery rate of offending vessels and cure rate.
[1] Bendtsen L, Zakrzewska JM, Heinskou TB, et al. Advances in diagnosis,classification，pathophysiology,and management of trigeminal neuralgia[J].Lancet Neurol, 2020，19( 9) : 784 -796．DOI: 10.1016/S1474-4422(20)30233-7.
[2] Sharma R, Phalak M, Katiyar V, et al. Microvascular decompression versus stereotactic radiosurgery as primary treatment modality for trigeminal neuralgia: A systematic review and meta-analysis of prospective comparative trials[J]. Neurol India, 2018, 66(3):688-694. DOI: 10.4103/0028-3886.232342.
[3] Rastogi S, Agarwal A, Bansal M, et al. Percutaneous balloon compression of Gasserian ganglion for idiopathic trigeminal neuralgia[J]. Indian Journal of Pain, 2019, 33(3):136-140. DOI: 10.4103/ijpn.ijpn_55_19.
[4] Crespi J, Bratbak D, Dodick DW,et al. Pilot study of injection of onabotulinumtoxina toward the sphenopalatine ganglion for the treatment of classical trigeminal neuralgia[J]. Headache, 2019, 59(8):1229-1239. DOI: 10.1111/head.13608.
[5] Patel SK, Markosian C, Choudhry OJ, et al. The historical evolution of microvascular decompression for trigeminal neuralgia: from Dandy's discovery to Jannetta's legacy[J]. Acta Neurochir, 2020, 162(11):2773-2782. DOI: 10.1007/s00701-020-04405-7.
[6] Di Carlo DT, Benedetto N, Marani W, et al. Microvascular decompression for trigeminal neuralgia due to vertebrobasilar artery compression: a systematic review and meta-analysis[J]. Neurosurg Rev, 2022, 45(1):285-294. DOI: 10.1007/s10143-021-01606-1.
[7] 李海红, 常成, 晁艳艳, 等. 全内镜微血管减压术治疗原发性三叉神经痛远期疗效随访研究[J]. 重庆医学, 2022, 51(13): 2208-2211.
[8] Nicola M, Alessandro R, Eleonora I, et al. Microvascular decompression in patients with trigeminal neuralgia and multiple sclerosis: results and analysis of possible prognostic factors.[J] . Acta Neurol Belg,2020,120（2）:329-334. DOI: 10.1007/s13760-019-01258-5.
[9] Urculo E, Elua A, Arrazola M, et al. Trigeminal root massage in microsurgical treatment of trigeminal neuralgia patients without arterial compression: when, how and why [J]. Neurocirugia (Astur), 2020, 31(2): 53-63. DOI: 10.1016/j.neucir.2019.07.003.
[10] Jiao L, Ye H, Lv J, Xie Y, Sun W, Ding G, et al. A Systematic Review of Repeat Microvascular Decompression for Recurrent or Persistent Trigeminal Neuralgia[J]. World Neurosurg. 2022,158:226-233. DOI: 10.1016/j.wneu.2021.11.129.
[11] Liang X, Dong X, Zhao S, et al. A retrospective study of neurocombing for the treatment of trigeminal neuralgia without neurovascular compression[J]. Ir J Med Sci, 2017,186( 4) : 1033-1039. DOI: 10.1007/s11845-016-1547-y.
[12] Shi J, Qian Y, Han W, et al. Risk factors for outcomes after microvascular decompression for trigeminal neuralgia [J].World Neurosurg, 2020,136: e559-e566. DOI: 10.1016/j.wneu.2020.01.082.
[13]Zhao XS, Hao M, Wang C, et al. Management of veins during microvascular decompression for idiopathic trigeminal neuralgia[J].Br J Neurosurg, 2018,32( 5) :484-488．
京ICP备08002354号-3
